![](/img/cover-not-exists.png)
A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study
Matsuda, Chu, Honda, Michitaka, Tanaka, Chihiro, Kondo, Ken, Takahashi, Takao, Kosugi, Chihiro, Tokunaga, Yukihiko, Takemoto, Hiroyoshi, Kim, Ho Min, Sakamoto, Junichi, Oba, Koji, Mishima, HideyukiLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-018-3568-x
Date:
April, 2018
File:
PDF, 780 KB
english, 2018